US President Donald Trump has imposed a 50% tariff on copper and warned that pharmaceutical imports could face tariffs of up to 200% within a year. This move could significantly impact India, which exported $360 million worth of copper and $9.8 billion worth of pharmaceuticals to the US in 2024–25. Trump also hinted at tariffs on semiconductors and reiterated a 10% tariff threat on BRICS nations, dismissing the bloc as “not serious” but acknowledging its challenge to the US dollar. While India’s copper industry may absorb the tariff shock, the pharma sector, vital to US healthcare, could face severe consequences.